Skip to main content

Table 3 Surgical Outcomes Summary

From: Safety and efficacy outcomes of the Xen45 Gel Stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospital

 

Subjects, n (%)

Total failure rate

6 (21.4)

Intraocular pressure not ≥20% reduction from baseline

3 (10.7)

Secondary surgical intervention

3 (10.7)

Postoperative Increase in antiglaucoma medications

0 (0.0)

Lost to follow-up prior to postoperative month 12a

13 (46.4)

  1. aPatients lost to follow-up were censored in survival analysis